Evidence and considerations in PrEP and PEP use
Selected Abstracts from the 2023 CROI Conference
Discussion of use of LAI ART for persons with…
Injectable ART for those with detectable viral…
Data on the newly approved medication Lenacapavir
HIV Treatment Guidelines
Update on long-acting Cabotegravir asPrEP,…
The "how to" of using Cabotegravir/…
How to integrate long-acting injectable ART into…
Overview of long-acting injectable Cabotegravir…
Overview of long-acting injectable Cabotegravir…